Desq Long
Sign in
SEC FORM 4
$6,768.90

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 1,635 shares at $4.14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 22, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001193125-26-398204 · filed 2026-09-22 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "4D Molecular Therapeutics, Inc. (FDMT)." Disclosed 2026-09-22. https://desqlong.com/cards/0001193125-26-398204-1 (retrieved 2026-09-26).